Irbaz Bin Riaz
- Oncology top 5%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Public Health, Environmental and Occupational Health top 5%
- Co-authors
- M. Hassan MuradJawad BilalFaiz AnwerHaris RiazAbbas RanaRainer W.G. GruessnerAngelika C. GruessnerMuhammad Shahzeb Khan
- Topics
- Prostate Cancer Treatment and Research (37 papers)Cancer Treatment and Pharmacology (20 papers)Radiopharmaceutical Chemistry and Applications (19 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesPakistanUnited Kingdom
In The Last Decade
Irbaz Bin Riaz
185 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Oncology 785
- Surgery 747
- Pulmonary and Respiratory Medicine 611
- Immunology 446
- Public Health, Environmental and Occupational Health 435
Countries citing papers authored by Irbaz Bin Riaz
This map shows the geographic impact of Irbaz Bin Riaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irbaz Bin Riaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irbaz Bin Riaz more than expected).
Fields of papers citing papers by Irbaz Bin Riaz
This network shows the impact of papers produced by Irbaz Bin Riaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irbaz Bin Riaz. The network helps show where Irbaz Bin Riaz may publish in the future.
Co-authorship network of co-authors of Irbaz Bin Riaz
This figure shows the co-authorship network connecting the top 25 collaborators of Irbaz Bin Riaz. A scholar is included among the top collaborators of Irbaz Bin Riaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irbaz Bin Riaz. Irbaz Bin Riaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 9 | |
| 9 | 2 | |
| 10 | 10 | |
| 11 | 21 | |
| 12 | 1 | |
| 13 | Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial | 20 |
| 14 | 24 | |
| 15 | 65 | |
| 16 | 10 | |
| 17 | 31 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 1 |
About Irbaz Bin Riaz
Irbaz Bin Riaz is a scholar working on Health Informatics, Internal Medicine and Oncology, having authored 213 papers that have together received 3.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (37 papers), Cancer Treatment and Pharmacology (20 papers) and Radiopharmaceutical Chemistry and Applications (19 papers). The work is most often cited by research in Transplantation (197 citations), Health Informatics (61 citations) and Internal Medicine (151 citations). Irbaz Bin Riaz has collaborated with scholars based in United States, Pakistan and United Kingdom. Frequent co-authors include M. Hassan Murad, Jawad Bilal, Faiz Anwer, Haris Riaz, Abbas Rana, Rainer W.G. Gruessner, Angelika C. Gruessner, Muhammad Shahzeb Khan, Bruce Kaplan and Muhammad Husnain. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.